Perfil
Kimberley S.
Gannon worked as a Senior Director-Biology at Predix Pharmaceuticals, Inc., Senior VP-Preclinical Research & Development at Proclara Biosciences, Inc., Vice President-Research & Development at Ischemix, Inc., Head-US Operations at Eolas Biosciences Co., Ltd., and Chief Scientific Officer at Lysogene SA. She received a doctorate degree from Florida State University in 1994.
Antiguos cargos conocidos de Kimberley S. Gannon.
| Empresas | Cargo | Fin |
|---|---|---|
| LYSOGENE | Director Técnico/Científico/I+D | 02/05/2018 |
Eolas Biosciences Co., Ltd. | Corporate Officer/Principal | - |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Corporate Officer/Principal | - |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Corporate Officer/Principal | - |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Director Técnico/Científico/I+D | - |
Formación de Kimberley S. Gannon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs | Health Technology |
Eolas Biosciences Co., Ltd. | |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
- Bolsa de valores
- Insiders
- Kimberley S. Gannon
















